Feedback
Cytogenomic Molecular Inversion Probe Array, FFPE Tissue - Products of Conception 
2010795
Ordering Recommendation

For detection of copy number alterations and loss of heterozygosity in FFPE specimens from products of conception.

Mnemonic
CMA PFFPE
Methodology
Molecular Inversion Probe Array
Performed
Sun-Sat
Reported
2-3 weeks
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Submit With Order
Specimen Required
Patient Preparation
 
Collect
Fetal autopsy or products of conception. 
Specimen Preparation
FFPE Fetal tissue: Transport ten slides, each with 5 µm unstained sections or four 20 µm scrolls or tissue block.
OR FFPE villi: Transport one H&E stained slide and ten slides, each with 5 µm unstained sections or tissue block. 
Storage/Transport Temperature
Room temperature. Also acceptable: Refrigerated. Ship in cooled container during summer months. 
Unacceptable Conditions
Specimens fixed or processed in alternative fixatives or heavy metal fixatives (B-4 or B-5). 
Remarks
Please submit the Patient History Form - Cytogenetics (Chromosome) Testing, Prenatal with the Electronic Packing List. The form is available on ARUP's Web site, http://www.aruplab.com/genetics/resources/patient-history. 
Stability
Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable 
Reference Interval
Interpretive Data
For detection of copy number alterations and loss of heterozygosity in FFPE specimens.
Refer to report.

Compliance Statement C: The performance characteristics of this test were validated by ARUP Laboratories. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test. However, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. ARUP is authorized under Clinical Laboratory Improvement Amendments (CLIA) and by all states to perform high-complexity testing. Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

Note
If sending placenta instead of fetal tissue, at least 80% villi for products of conception specimens.
Components
Component Test Code*Component Chart NameLOINC
2010796Cytogenomic MIP Array FFPE, POC
2010877EER Cytogenomic MIP Array FFPE, POC11526-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • aCGH
  • anomalies
  • array CGH
  • Array Comparative Genomic Hybridization
  • birth defects
  • Chromosomal Microarray
  • CMA; CGH
  • Down
  • Down syndrome
  • Edward
  • Edward syndrome
  • MCA; XO; 45,X; 45X
  • Microarray
  • microdeletion
  • microduplication
  • miscarriage
  • monosomy
  • multiple congenital anomalies
  • Patau
  • Patau syndrome
  • product of conception, POC, villi, placenta, fetal loss, fetal demise, abortion, pregnancy loss, sti
  • SAB
  • Single-nucleotide-polymorphism (SNP) array
  • T13; T18; T21
  • tissue
  • trisomy 13
  • Trisomy 18
  • Trisomy 21
  • Turner
  • Turner syndrome
  • Whole Genome Array, formalin-fixed, paraffin-embedded, FFPE